3,0
21 jan 2012
Huidige werknemer
Philadelphia, PA
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Great to be creating something that cures diseases Benefits are good (middle of road for pharma) Great when compared to other industries
Minpunten
Constant churn due to merger and reorganizations. Unable to create new products that can replace those facing the patent cliff makes it a company that has a lot of stress.